EBUS/Spectrum Analysis

Completed

• Conditions: Lung Cancer
• Interventions: Device: Spectrum Image Analysis using a Linear Array Ultrasound Bronchoscope

• Registration Number: NCT01972386
• Lead Sponsor: University Health Network, Toronto

Brief Summary

To evaluate the clinical benefit of spectrum analysis of endobronchial ultrasound images of lymph nodes during EBUS TBNA for lymph node staging in patients with lung cancer.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-09
• Study First Submitted: 2013-10-08
• Study First Submitted QC: 2013-10-24
• Study First Posted: 2013-10-30
• Primary Completion: 2015-09
• Study Completion: 2016-01
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-22
• Last Update Posted: 2018-02-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

• Ages 18 years or older
• Patients with known or suspected lung cancer who require EBUS-TBNA for lymph node staging

Exclusion Criteria

• Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy
• Inability to give informed consent
• Patients who are pregnant

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Spectrum Image Analysis	Spectrum Image Analysis using a Linear Array Ultrasound Bronchoscope	-

Primary Outcome Measures

Name	Time	Method
Lymph Node Staging	Pathology report will be completed as soon as possible after the procedure. (Within one year)	The lymph node staging will be determined by the pathology report of the biopsy taken from the patients lymph node(s).

Trial Locations

Locations (1)

University Health Network; 🇨🇦 Toronto, Ontario, Canada